Now Enrolling: Chikungunya Virus Vaccine Clinical Trial
Call now, or fill out the form below, for more information.
727-768-5893 Mon – Fri 8am-8pm
Chikungunya Vaccine Study
- Chikungunya is a virus that can be spread through mosquito bites similar to other mosquito-spread illnesses like Zika, malaria, dengue, and West Nile Virus. GCP Research is conducting a study to test the effectiveness of a phase 3 vaccine to prevent Chikungunya in people who are 65 or older. The study will be 7 months long and consists of 5 office visits and 2 phone call appointments.
- Ages: 65+
- Compensation: $900*
- Study Topic: Chikungunya Virus
*Compensation for time and travel may be available to those who qualify.